Pharmnovo takes on an Angel Investor

Date: September 30,  2014

Pharmnovo has established a long term partnership with an Angel Investor. In the light of this the company will start several new projects and a commitment to clinical safety work in the new Pharmnovo UK.

Read More

Pharmnovo UK Ltd was recently established with the mission to progress our candidate drugs to Phase I clinical.

Read More

Pharmnovo has, over a number of years worked with novel molecules for the treatment of Chronic Pain. Our first patent application is a joint activity between On Target Pharmaceuticals and Pharmnovo. These two companies will now move forward together in a novel drug discovery constellation called.

Read More

The Pharmnovo pre-clinical/clinical delta agonist receptor opioid project and project portfolio will be presented in a pitch presentation at the Nordic Life Science Days (NLSD) 14-15 October in.

Read More